glp-1 drugs pharmaceutical companies news 2025 trends 2025: real-world data, patient outcomes & future therapies GLP-1 Antagonists Increase Plan Drug
Description
doi:10.1210/en.2012-1937 Jin T, Weng J
Healthline Media does not provide medical advice, diagnosis, or treatment
Looking ahead, as the GLP-1 class of drugs continues to improve and side effects decrease, there is a potential future where many people incorporate a GLP-1 derivative into their daily routine
Authors contributions Drafting the manuscript, creating figures and tables (WMW), and critically revising the document for important intellectual content (LGL)
In individuals with AD, GLP-1RAs did not exert disease-modifying effects on cognition
